MX2009005578A - Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre. - Google Patents

Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre.

Info

Publication number
MX2009005578A
MX2009005578A MX2009005578A MX2009005578A MX2009005578A MX 2009005578 A MX2009005578 A MX 2009005578A MX 2009005578 A MX2009005578 A MX 2009005578A MX 2009005578 A MX2009005578 A MX 2009005578A MX 2009005578 A MX2009005578 A MX 2009005578A
Authority
MX
Mexico
Prior art keywords
wuth
blood platelet
reducing properties
platelet reducing
derivatives
Prior art date
Application number
MX2009005578A
Other languages
English (en)
Inventor
Richard Franklin
Bernard Golding
Original Assignee
Shire Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Llc filed Critical Shire Llc
Publication of MX2009005578A publication Critical patent/MX2009005578A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere al descubrimiento de profármacos de análogos 3- ó 5-sustituidos del agente reductor de plaquetas selectivo anagrelida que tienen potencial reducido para efectos colaterales cardiovasculares y que por lo tanto deben conducir a acatamiento por el paciente y seguridad mejorados en el tratamiento de enfermedades mieloproliferativas; de manera más específica, la presente invención se refiere a profármacos de ciertos derivados de imidazoquinazolina que tienen utilidad como agentes reductores de plaquetas en humanos; los compuestos de la presente invención funcionan inhibiendo la formación de plaquetas de la sangre.
MX2009005578A 2006-11-28 2007-11-19 Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre. MX2009005578A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0623749.9A GB0623749D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines
PCT/GB2007/050698 WO2008065445A1 (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives wuth blood platelet reducing properties

Publications (1)

Publication Number Publication Date
MX2009005578A true MX2009005578A (es) 2009-07-29

Family

ID=37671459

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005578A MX2009005578A (es) 2006-11-28 2007-11-19 Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre.

Country Status (15)

Country Link
EP (1) EP2097390A1 (es)
JP (1) JP2010511031A (es)
KR (1) KR20090089865A (es)
CN (1) CN101558048B (es)
AR (1) AR064003A1 (es)
AU (1) AU2007327048B2 (es)
BR (1) BRPI0719568A2 (es)
CA (1) CA2670168A1 (es)
EA (1) EA017139B1 (es)
GB (1) GB0623749D0 (es)
IL (1) IL198808A0 (es)
MX (1) MX2009005578A (es)
MY (1) MY149620A (es)
TW (1) TW200829252A (es)
WO (1) WO2008065445A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822970D0 (en) * 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
CN103254197A (zh) * 2013-05-29 2013-08-21 黑龙江大学 一种盐酸阿那格雷的制备方法
PL3236967T3 (pl) 2014-12-22 2020-04-30 Suda Pharmaceuticals Ltd Zapobieganie i leczenie przerzutów u pacjentów z nadpłytkowością typu nowotworowego

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146718A (en) * 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
US6194420B1 (en) * 1999-11-30 2001-02-27 Roberts Laboratories Inc. 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
DE10301105B4 (de) * 2003-01-09 2005-11-24 Chemisch-Pharmazeutisches Labor, Rolf Sachse Gmbh Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation
EA010871B1 (ru) * 2003-01-23 2008-12-30 Шир Холдингз Аг Трансдермальные составы и способы лечения тромбоцитемии
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia

Also Published As

Publication number Publication date
BRPI0719568A2 (pt) 2013-12-10
MY149620A (en) 2013-09-13
JP2010511031A (ja) 2010-04-08
EP2097390A1 (en) 2009-09-09
TW200829252A (en) 2008-07-16
AU2007327048B2 (en) 2012-01-12
CN101558048B (zh) 2012-07-25
WO2008065445A1 (en) 2008-06-05
AU2007327048A1 (en) 2008-06-05
EA017139B1 (ru) 2012-10-30
IL198808A0 (en) 2010-02-17
GB0623749D0 (en) 2007-01-10
EA200900742A1 (ru) 2010-08-30
AR064003A1 (es) 2009-03-04
KR20090089865A (ko) 2009-08-24
CA2670168A1 (en) 2008-06-05
CN101558048A (zh) 2009-10-14

Similar Documents

Publication Publication Date Title
TW200736234A (en) Chemical compounds
TN2009000137A1 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
ZA200703002B (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
TW200744586A (en) Therapeutic compounds
MX2007008924A (es) Compuestos quimicos.
EA201300556A1 (ru) Аминоспиртзамещенные производные 2,3-дигидроимидазо[1,2-с] хиназолина, пригодные для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
TW200634003A (en) Chemical compounds
WO2010111406A3 (en) Purine derivatives useful as anti - cancer agents
TW200616974A (en) Chemical compounds
WO2008033562A3 (en) Kinase inhibitor compounds
MX2012002480A (es) Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer.
MX2010007523A (es) Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer.
WO2006116733A3 (en) Protein kinase inhibitors
MX2010007584A (es) Inhibidores de proteina cinasa y uso de los mismos.
MX2009003724A (es) Derivados de 2-aminocarbonil-piridina.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
TW200628473A (en) Novel heterocycles
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
MX2009004906A (es) Sulfonamidas heterociclicas que tienen actividad antagonistica del edg-1.
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
MX2009005579A (es) Quinazolinas sustituidas.
MX2009005578A (es) Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre.
MX2008011020A (es) Compuestos de receptor sigma.
WO2009138796A3 (en) Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal